frequentist network meta analysis nma Search Results


99
STATA Corporation frequentist network meta analysis nma
Network diagram of comparative <t>network</t> <t>meta-analysis</t> for CETP inhibitor-based regimens. Each node represents a treatment, with size proportional to the number of included studies. Lines indicate direct comparisons between treatments. CETP, cholesteryl ester transfer protein.
Frequentist Network Meta Analysis Nma, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/frequentist+network+meta+analysis+nma/STATA+14%2E0/pmc13043226-51-3-8
Average 99 stars, based on 1 article reviews
frequentist network meta analysis nma - by Bioz Stars, 2026-09
99/100 stars
  Buy from Supplier

Image Search Results


Network diagram of comparative network meta-analysis for CETP inhibitor-based regimens. Each node represents a treatment, with size proportional to the number of included studies. Lines indicate direct comparisons between treatments. CETP, cholesteryl ester transfer protein.

Journal: Journal of Cardiovascular Pharmacology

Article Title: Lipid-Lowering Efficacy and Adverse Events of CETP Inhibitor Combination Therapy: A Systematic Review and Network Meta-Analysis

doi: 10.1097/FJC.0000000000001785

Figure Lengend Snippet: Network diagram of comparative network meta-analysis for CETP inhibitor-based regimens. Each node represents a treatment, with size proportional to the number of included studies. Lines indicate direct comparisons between treatments. CETP, cholesteryl ester transfer protein.

Article Snippet: We conducted a frequentist network meta-analysis (NMA) using Stata 14.0.

Techniques:

Network meta-analysis results for ApoAI and ApoB. A and C show MDs with 95% confidence intervals; positive values indicate higher ApoAI or lower ApoB. B and D display cumulative ranking probabilities (SUCRA). ApoAI, apolipoprotein A-I; ApoB, apolipoprotein B.

Journal: Journal of Cardiovascular Pharmacology

Article Title: Lipid-Lowering Efficacy and Adverse Events of CETP Inhibitor Combination Therapy: A Systematic Review and Network Meta-Analysis

doi: 10.1097/FJC.0000000000001785

Figure Lengend Snippet: Network meta-analysis results for ApoAI and ApoB. A and C show MDs with 95% confidence intervals; positive values indicate higher ApoAI or lower ApoB. B and D display cumulative ranking probabilities (SUCRA). ApoAI, apolipoprotein A-I; ApoB, apolipoprotein B.

Article Snippet: We conducted a frequentist network meta-analysis (NMA) using Stata 14.0.

Techniques: